ArticleCureus2025
Atypical Early Onset Alzheimer's Disease in a Young Female: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early-onset Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the development of amyloid plaques and neurofibrillary tangles at an earlier age. It affects multiple cognitive domains, including memory, executive function, and motor abilities. Here, we present a case of atypical early-onset AD. A 33-year-old woman with no significant medical history experienced a two-year decline in cognitive function, resulting in job loss and incidents such as cooking-related fires. Neurological examination revealed impaired attention, myoclonus, hyperreflexia, and a dystaxic gait. Imaging and tests showed minor abnormalities, with normal cerebrospinal fluid (CSF), genetic, autoimmune, and metabolic workups. Brain magnetic resonance imaging (MRI) and positron emission tomography (PET) fluorodeoxyglucose (FDG) scans indicated cortical atrophy and parietal hypometabolism. The patient was referred to a memory center for further evaluation and potential treatment with lecanemab. This case highlights the challenges in diagnosing early-onset neurodegenerative disorders, which can present atypically and mimic other conditions. The extensive diagnostic workup emphasizes the difficulty of diagnosing these disorders, particularly in the absence of specific biomarkers. Early diagnosis of neurodegenerative disorders in young adults requires heightened clinical suspicion and a comprehensive diagnostic workup, including advanced brain imaging, such as MRI and PET scans, to ensure timely diagnosis and referral to specialized centers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.